According to WHO guidelines, individuals at risk include close contacts of patients with active TB, migrants, health care workers, patients with diabetes, and immunocompromised patients with HIV infection, chronic renal failure or receiving immunosuppressive drug therapy, treatment with TNF antagonists or other biological therapeutics [46]. This evidence concerns the gene TNF and HIV infectious disease.